Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)

NCT02923154 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

NASH

Interventions

DRUG: MT-3995
DRUG: Placebo

Sponsor

Tanabe Pharma Corporation